Integra LifeSciences Holdings Corp Stock
The price for the Integra LifeSciences Holdings Corp stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.680%).
Currently there is a rather negative sentiment for Integra LifeSciences Holdings Corp with 0 Buy predictions and 5 Sell predictions..
A potential of -38.78%, resulting from comparing the current price of 14.7 € with the target price of 9 € for Integra LifeSciences Holdings Corp, shows the chance of incurring significant losses.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | -0.680% | 10.072% | 29.661% | 27.500% | 44.340% | -59.524% | -73.158% |
| Haemonetics Corp. | 1.540% | 17.094% | 52.902% | - | 0.000% | - | - |
| Bio-Rad Labs Inc. A | -0.080% | -3.951% | 17.037% | 26.085% | -1.978% | -24.807% | -47.113% |
| CONMED Corp. | 0.000% | 11.268% | 1.282% | -39.231% | -9.714% | -73.884% | -71.009% |
Comments
Integra LifeSciences (IART) had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target lowered by Citigroup Inc. from $11.00 to $9.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
News
Integra Resources Q1 Earnings Call Highlights
Integra Resources (NYSEAMERICAN:ITRG) reported first-quarter 2026 results that management said reflected a deliberate reinvestment phase at its Florida Canyon mine, alongside continued permitting
